BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Letteron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol. 1996;24:200-208. [PMID: 8907574 DOI: 10.1016/s0168-8278(96)80030-4] [Cited by in Crossref: 184] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res 2010;51:1513-23. [PMID: 20124555 DOI: 10.1194/jlr.M004812] [Cited by in Crossref: 212] [Cited by in F6Publishing: 106] [Article Influence: 19.3] [Reference Citation Analysis]
2 Bijnen M, van Greevenbroek MMJ, van der Kallen CJH, Scheijen JL, van de Waarenburg MPH, Stehouwer CDA, Wouters K, Schalkwijk CG. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study. J Diabetes Res 2019;2019:6289831. [PMID: 31218233 DOI: 10.1155/2019/6289831] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
3 Szalowska E, van der Burg B, Man HY, Hendriksen PJ, Peijnenburg AA. Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices. PLoS One. 2014;9:e86795. [PMID: 24489787 DOI: 10.1371/journal.pone.0086795] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
4 Okan A, Astarcioglu H, Tankurt E, Sagol O, Altekin E, Astarcioglu I, Gonen O. Effect of ursodeoxycholic acid on hepatic steatosis in rats. Dig Dis Sci. 2002;47:2389-2397. [PMID: 12452368 DOI: 10.1023/A:1020523017873] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Liu Y, He J, Ji S, Wang Q, Pu H, Jiang T, Meng L, Yang X, Ji J. Comparative studies of early liver dysfunction in senescence-accelerated mouse using mitochondrial proteomics approaches. Mol Cell Proteomics. 2008;7:1737-1747. [PMID: 18515266 DOI: 10.1074/mcp.m800109-mcp200] [Cited by in Crossref: 49] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
6 Wang JW, Wan XY, Zhu HT, Lu C, Yu WL, Yu CH, Shen Z, Li YM. Lipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cells. PLoS One 2014;9:e96124. [PMID: 24788149 DOI: 10.1371/journal.pone.0096124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fukunishi S, Nishio H, Fukuda A, Takeshita A, Hanafusa T, Higuchi K, Suzuki K. Development of Fibrosis in Nonalcoholic Steatosis through Combination of a Synthetic Diet Rich in Disaccharide and Low-Dose Lipopolysaccharides in the Livers of Zucker (fa/fa) Rats. J Clin Biochem Nutr. 2009;45:322-328. [PMID: 19902023 DOI: 10.3164/jcbn.09-50] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
8 Natarajan SK, Thangaraj KR, Goel A, Eapen CE, Balasubramanian KA, Ramachandran A. Acute fatty liver of pregnancy: an update on mechanisms. Obstet Med 2011;4:99-103. [PMID: 27579101 DOI: 10.1258/om.2011.100071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
9 Al Zarzour RH, Ahmad M, Asmawi MZ, Kaur G, Saeed MAA, Al-Mansoub MA, Saghir SAM, Usman NS, Al-Dulaimi DW, Yam MF. Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats. Nutrients. 2017;9:776. [PMID: 28718838 DOI: 10.3390/nu9070766] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
10 Kitase A, Hino K, Furutani T, Okuda M, Gondo T, Hidaka I, Hara Y, Yamaguchi Y, Okita K. In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis. J Gastroenterol. 2005;40:617-624. [PMID: 16007396 DOI: 10.1007/s00535-005-1596-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
11 Riquelme A, Soza A, Nazal L, Martínez G, Kolbach M, Patillo A, Arellano JM, Duarte I, Martínez J, Molgó M, Arrese M. Histological resolution of steatohepatitis after iron depletion. Dig Dis Sci 2004;49:1012-5. [PMID: 15309893 DOI: 10.1023/b:ddas.0000034564.68307.39] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
12 Nyman LR, Tian L, Hamm DA, Schoeb TR, Gower BA, Nagy TR, Wood PA. Long term effects of high fat or high carbohydrate diets on glucose tolerance in mice with heterozygous carnitine palmitoyltransferase-1a (CPT-1a) deficiency: Diet influences on CPT1a deficient mice. Nutr Diabetes 2011;1:e14. [PMID: 22229081 DOI: 10.1038/nutd.2011.11] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
13 Mouralidarane A, Lin CI, Suleyman N, Soeda J, Oben JA. Practical management of the increasing burden of non-alcoholic fatty liver disease. Frontline Gastroenterol 2010;1:149-55. [PMID: 28839568 DOI: 10.1136/fg.2009.000935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Hatzis G, Ziakas P, Kavantzas N, Triantafyllou A, Sigalas P, Andreadou I, Ioannidis K, Chatzis S, Filis K, Papalampros A. Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J Hepatol. 2013;5:160-169. [PMID: 23671720 DOI: 10.4254/wjh.v5.i4.160] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
15 Piao YF, Li JT, Shi Y. Relationship between genetic polymorphism of cytochrome P450IIE1 and fatty liver. World J Gastroenterol 2003;9:2612-5. [PMID: 14606109 DOI: 10.3748/wjg.v9.i11.2612] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
16 Ramai D, Tai W, Rivera M, Facciorusso A, Tartaglia N, Pacilli M, Ambrosi A, Cotsoglou C, Sacco R. Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma. Biomedicines 2021;9:184. [PMID: 33673113 DOI: 10.3390/biomedicines9020184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Xu Z, Chen L, Leung L, Yen TS, Lee C, Chan JY. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci U S A 2005;102:4120-5. [PMID: 15738389 DOI: 10.1073/pnas.0500660102] [Cited by in Crossref: 187] [Cited by in F6Publishing: 172] [Article Influence: 11.7] [Reference Citation Analysis]
18 Esteban-Zubero E, García-Gil FA, López-Pingarrón L, Alatorre-Jiménez MA, Ramírez JM, Tan DX, García JJ, Reiter RJ. Melatonin role preventing steatohepatitis and improving liver transplantation results. Cell Mol Life Sci 2016;73:2911-27. [PMID: 27022943 DOI: 10.1007/s00018-016-2185-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
19 Hadzi-Petrushev N, Dimovska K, Jankulovski N, Mitrov D, Mladenov M. Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease's Statin Therapy in Men. Adv Pharmacol Sci 2018;2018:4673061. [PMID: 29887885 DOI: 10.1155/2018/4673061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhu MJ, Sun LJ, Liu YQ, Feng YL, Tong HT, Hu YH, Zhao Z. Blood F2-isoprostanes are significantly associated with abnormalities of lipid status in rats with steatosis. World J Gastroenterol 2008;14:4677-83. [PMID: 18698683 DOI: 10.3748/wjg.14.4677] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
21 Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000;105:1067-75. [PMID: 10772651 DOI: 10.1172/JCI8814] [Cited by in Crossref: 523] [Cited by in F6Publishing: 185] [Article Influence: 24.9] [Reference Citation Analysis]
22 Carvajal S, Perramón M, Oró D, Casals E, Fernández-Varo G, Casals G, Parra M, González de la Presa B, Ribera J, Pastor Ó, Morales-Ruíz M, Puntes V, Jiménez W. Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease. Sci Rep 2019;9:12848. [PMID: 31492960 DOI: 10.1038/s41598-019-49262-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
23 Prince E, Lazare FB, Treem WR, Xu J, Iqbal J, Pan X, Josekutty J, Walsh M, Anderson V, Hussain MM, Schwarz SM. Ω-3 fatty acids prevent hepatic steatosis, independent of PPAR-α activity, in a murine model of parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr 2014;38:608-16. [PMID: 23757305 DOI: 10.1177/0148607113491436] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
24 Albano E, Mottaran E, Vidali M, Reale E, Saksena S, Occhino G, Burt AD, Day CP. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut. 2005;54:987-993. [PMID: 15951547 DOI: 10.1136/gut.2004.057968] [Cited by in Crossref: 135] [Cited by in F6Publishing: 128] [Article Influence: 8.4] [Reference Citation Analysis]
25 Lin JC, Peng YJ, Wang SY, Young TH, Salter DM, Lee HS. Role of the sympathetic nervous system in carbon tetrachloride-induced hepatotoxicity and systemic inflammation. PLoS One 2015;10:e0121365. [PMID: 25799095 DOI: 10.1371/journal.pone.0121365] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
26 Patel V, Sanyal AJ. Drug-induced steatohepatitis. Clin Liver Dis 2013;17:533-46, vii. [PMID: 24099016 DOI: 10.1016/j.cld.2013.07.012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
27 Cortez-Pinto H, Baptista A, Camilo ME, De Moura MC. Nonalcoholic steatohepatitis--a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci. 2003;48:1909-1913. [PMID: 14627331 DOI: 10.1023/a:1026152415917] [Cited by in Crossref: 40] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
28 Deenin W, Malakul W, Boonsong T, Phoungpetchara I, Tunsophon S. Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression. World J Hepatol 2021;13:315-27. [PMID: 33815675 DOI: 10.4254/wjh.v13.i3.315] [Reference Citation Analysis]
29 Chong CLG, Hussan F, Othman F. Hepatoprotective Effects of Morinda citrifolia Leaf Extract on Ovariectomized Rats Fed with Thermoxidized Palm Oil Diet: Evidence at Histological and Ultrastructural Level. Oxid Med Cell Longev 2019;2019:9714302. [PMID: 31827717 DOI: 10.1155/2019/9714302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Abdelmegeed MA, Moon KH, Hardwick JP, Gonzalez FJ, Song BJ. Role of peroxisome proliferator-activated receptor-alpha in fasting-mediated oxidative stress. Free Radic Biol Med. 2009;47:767-778. [PMID: 19539749 DOI: 10.1016/j.freeradbiomed.2009.06.017] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
31 Ziada DH, El Saadany S, Enaba M, Ghazy M, Hasan A. The interaction between insulin resistance, liver fibrosis and early virological response in Egyptian patients with chronic hepatitis C. Can J Gastroenterol 2012;26:325-9. [PMID: 22720272 DOI: 10.1155/2012/291457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
32 Zafrani ES. Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch. 2004;444:3-12. [PMID: 14685853 DOI: 10.1007/s00428-003-0943-7] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
33 Magosso E, Ansari MA, Gopalan Y, Shuaib IL, Wong JW, Khan NA, Abu Bakar MR, Ng BH, Yuen KH. Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial. Nutr J. 2013;12:166. [PMID: 24373555 DOI: 10.1186/1475-2891-12-166] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
34 Khorsandi L, Mansouri E, Orazizadeh M, Jozi Z. Curcumin Attenuates Hepatotoxicity Induced by Zinc Oxide Nanoparticles in Rats. Balkan Med J 2016;33:252-7. [PMID: 27308068 DOI: 10.5152/balkanmedj.2016.150017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
35 Bhardwaj P, Madan K, Thareja S, Joshi YK, Saraya A. Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease. Hepatol Int 2008;2:202-8. [PMID: 19669305 DOI: 10.1007/s12072-008-9060-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
36 Jung S, Lee SH, Song YS, Lee SY, Kim SY, Ko KS. Effect of Beverage Containing Fermented Akebia quinata Extracts on Alcoholic Hangover. Prev Nutr Food Sci 2016;21:9-13. [PMID: 27069900 DOI: 10.3746/pnf.2016.21.1.9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
37 Ratziu V, Trabut JB, Poynard T. Fat, diabetes, and liver injury in chronic hepatitis C. Curr Gastroenterol Rep. 2004;6:22-29. [PMID: 14720450 DOI: 10.1007/s11894-004-0022-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
38 Willebrords J, Pereira IV, Maes M, Crespo Yanguas S, Colle I, Van Den Bossche B, Da Silva TC, de Oliveira CP, Andraus W, Alves VA. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Prog Lipid Res. 2015;59:106-125. [PMID: 26073454 DOI: 10.1016/j.plipres.2015.05.002] [Cited by in Crossref: 85] [Cited by in F6Publishing: 72] [Article Influence: 14.2] [Reference Citation Analysis]
39 Malaguarnera L, Di Rosa M, Zambito AM, dell’Ombra N, Nicoletti F, Malaguarnera M. Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut. 2006;55:1313-1320. [PMID: 16825325 DOI: 10.1136/gut.2005.075697] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 4.5] [Reference Citation Analysis]
40 Duvnjak M, Lerotić I, Barsić N, Tomasić V, Virović Jukić L, Velagić V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol 2007;13:4539-50. [PMID: 17729403 DOI: 10.3748/wjg.v13.i34.4539] [Cited by in CrossRef: 153] [Cited by in F6Publishing: 138] [Article Influence: 10.9] [Reference Citation Analysis]
41 Kim H, Lee DS, An TH, Park HJ, Kim WK, Bae KH, Oh KJ. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. Int J Mol Sci 2021;22:4495. [PMID: 33925827 DOI: 10.3390/ijms22094495] [Reference Citation Analysis]
42 Fartoux L, Poujol-Robert A, Guéchot J, Wendum D, Poupon R, Serfaty L. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut. 2005;54:1003-1008. [PMID: 15951550 DOI: 10.1136/gut.2004.050302] [Cited by in Crossref: 262] [Cited by in F6Publishing: 239] [Article Influence: 16.4] [Reference Citation Analysis]
43 de Oliveira CP, Simplicio FI, de Lima VM, Yuahasi K, Lopasso FP, Alves VA, Abdalla DS, Carrilho FJ, Laurindo FR, de Oliveira MG. Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats. World J Gastroenterol 2006;12:1905-11. [PMID: 16609997 DOI: 10.3748/wjg.v12.i12.1905] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
44 García-galiano D, Sánchez-garrido MA, Espejo I, Montero JL, Costán G, Marchal T, Membrives A, Gallardo-valverde JM, Muñoz-castañeda JR, Arévalo E, De la Mata M, Muntané J. IL-6 and IGF-1 are Independent Prognostic Factors of Liver Steatosis and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients. OBES SURG 2007;17:493-503. [DOI: 10.1007/s11695-007-9087-1] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
45 Besse-Patin A, Estall JL. An Intimate Relationship between ROS and Insulin Signalling: Implications for Antioxidant Treatment of Fatty Liver Disease. Int J Cell Biol 2014;2014:519153. [PMID: 24672550 DOI: 10.1155/2014/519153] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
46 Oliveira CP, da Costa Gayotto LC, Tatai C, Della Bina BI, Janiszewski M, Lima ES, Abdalla DS, Lopasso FP, Laurindo FR, Laudanna AA. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J Cell Mol Med. 2002;6:399-406. [PMID: 12417056 DOI: 10.1111/j.1582-4934.2002.tb00518.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 4.7] [Reference Citation Analysis]
47 Ortiz-Avila O, Gallegos-Corona MA, Sánchez-Briones LA, Calderón-Cortés E, Montoya-Pérez R, Rodriguez-Orozco AR, Campos-García J, Saavedra-Molina A, Mejía-Zepeda R, Cortés-Rojo C. Protective effects of dietary avocado oil on impaired electron transport chain function and exacerbated oxidative stress in liver mitochondria from diabetic rats. J Bioenerg Biomembr 2015;47:337-53. [PMID: 26060181 DOI: 10.1007/s10863-015-9614-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
48 Sun H, Huang FF, Qu S. Melatonin: a potential intervention for hepatic steatosis. Lipids Health Dis 2015;14:75. [PMID: 26199093 DOI: 10.1186/s12944-015-0081-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
49 Shimizu I, Kohno N, Tamaki K, Shono M, Huang HW, He JH, Yao DF. Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World J Gastroenterol. 2007;13:4295-4305. [PMID: 17708600 DOI: 10.3748/wjg.v13.i32.4295] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 84] [Article Influence: 6.8] [Reference Citation Analysis]
50 Oliveira CP, Gayotto LC, Tatai C, Della Nina BI, Lima ES, Abdalla DS, Lopasso FP, Laurindo FR, Carrilho FJ. Vitamin C and vitamin E in prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in choline deficient diet fed rats. Nutr J 2003;2:9. [PMID: 14613504 DOI: 10.1186/1475-2891-2-9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
51 Nehra V, Angulo P, Buchman AL, Lindor KD. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci. 2001;46:2347-2352. [PMID: 11713934 DOI: 10.1023/a:1012338828418] [Cited by in Crossref: 107] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]